PMID: 26763061Jan 15, 2016Paper

Singapore Cancer Network (SCAN) Guidelines for the Systemic Therapy of Endometrial (Uterine) Cancer

Annals of the Academy of Medicine, Singapore
Singapore Cancer Network (SCAN) Gynaecological Cancers Systemic Therapy Workgroup

Abstract

The SCAN gynaecological cancers systemic therapy workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for the systemic therapy of endometrial (uterine) cancer. The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Three international guidelines were evaluated- those developed by the National Cancer Comprehensive Network (2015), the European Society of Medical Oncology (2013) and the Cancer Council Australia (2011). Recommendations on the role of chemotherapy following surgery in women diagnosed with endometrial cancer, the chemotherapeutic options for women with advanced or recurrent endometrial cancers and the role of chemotherapy in women with uterine papillary serous carcinoma or clear cell carcinoma were developed. These adapted guidelines form the SCAN Guidelines 2015 for the systemic therapy of endometrial (uterine) cancer.

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Annals of the Academy of Medicine, Singapore
Singapore Cancer Network (SCAN) Gynaecological Cancers Systemic Therapy Workgroup
Annals of the Academy of Medicine, Singapore
Singapore Cancer Network (SCAN) Genitourinary Cancer Workgroup
Annals of the Academy of Medicine, Singapore
Singapore Cancer Network (SCAN) Colorectal Cancer Systemic Therapy Workgroup
Annals of the Academy of Medicine, Singapore
Singapore Cancer Network (SCAN) Genitourinary Cancer Workgroup
Annals of the Academy of Medicine, Singapore
Singapore Cancer Network (SCAN) Genitourinary Cancer Workgroup
© 2022 Meta ULC. All rights reserved